Barbara S Wiggins

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Low Density Lipoprotein

Oral Anticoagulants

Pulmonary Embolism

Cardiovascular Risk Factors

Top Venues

American journal of cardiovascular drugs : drugs, devices, and other interventions

Journal of cardiovascular pharmacology

Pharmacotherapy

Journal of pharmacy practice

This page only lists publications with an associated author ORCID identifier.

Publications

Barbara S Wiggins
Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia. Journal of cardiovascular pharmacology 78 (5) (2022)
Barbara S Wiggins, James M Backes, Daniel Hilleman
Statin-associated muscle symptoms-A review: Individualizing the approach to optimize care. Pharmacotherapy 42 (5) (2022)
Eryne E Wiethorn, Carolyn Magee Bell, Barbara S Wiggins
Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60-120 Kilograms. American journal of cardiovascular drugs : drugs, devices, and other interventions 21 (5) (2021)
Barbara S Wiggins, Dave Dixon, Jessica Bellone, Nicole Gasbarro, Joel C Marrs, Rebecca Tran
Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update. Journal of pharmacy practice 33 (6) (2019)